Skip to main content
SpringerLink
Log in

Academic-industrial relationships: Opportunities and pitfalls

  • Published:
Science and Engineering Ethics Aims and scope Submit manuscript

Abstract

Over the past 50 years, academic-industrial collaborations and technology transfer have played an increasingly prominent role in the biomedical sciences. These relationships can speed the delivery of innovative drugs and medical technologies to clinical practice, creating important public health benefits as well as income for universities and their faculty. At the same time, they raise ethical concerns, particularly when research involves human subjects in clinical trials. Lapses in oversight of industry sponsored clinical trials at universities, and especially patient deaths in a number of trials, have brought these issues into the public spotlight and have led the federal government to intensify its oversight of clinical research. The leadership of Harvard Medical School convened a group of leaders in academic medicine to formulate guidelines on individual financial conflicts of interest. They and other groups are working to formulate a national consensus on this issue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Angell, M. (2000) Is academic medicine for sale? N Engl J Med 342(20): 1516–8.

    Article  Google Scholar 

  2. Weatherall, D. (2000) Academia and industry: increasingly uneasy bedfellows, Lancet 355(9215): 1574.

    Article  Google Scholar 

  3. Cho, M.K., Shohara, R., et al. (2000) Policies on faculty conflicts of interest at US universities, JAMA 284(17): 2203–8.

    Article  Google Scholar 

  4. Boyd, E.A. and Bero, L.A. (2000) Assessing faculty financial relationships with industry. A case study, JAMA 284(17): 2209–14.

    Article  Google Scholar 

  5. Lo, B., Wolf, L.E., et al. (2000) Conflict-of-interest policies for investigators in clinical trials, N Engl J Med 343(22): 1616–20.

    Article  Google Scholar 

  6. Martin, J.B. and Kasper, D.L. (2000) In whose best interest? Breaching the academic-industrial wall, N Engl J Med 343(22): 1646–9.

    Article  Google Scholar 

  7. Protecting Subjects, Preserving Trust, Promoting Progress: Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research (2001) Association of American Medical Colleges, Washington, D.C.

  8. Moses, H.3rd and Martin, J.B. (2001) Academic relationships with industry: a new model for biomedical research, JAMA 285(7): 933–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard Medical School, 25 Shattuck Street, Room 111, 02115, Boston, MA, USA

    Joseph B. Martin M.D., Ph.D. (Dean) & Thomas P. Reynolds

Authors
  1. Joseph B. Martin M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas P. Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph B. Martin M.D., Ph.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martin, J.B., Reynolds, T.P. Academic-industrial relationships: Opportunities and pitfalls. SCI ENG ETHICS 8, 443–454 (2002). https://doi.org/10.1007/s11948-002-0066-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11948-002-0066-6

Keywords

Search

Navigation